Value through Innovation17 January 2013

Your search results.

  1. Prof. Dr Dr Andreas Barner

    Prof. Dr Dr Andreas Barner,Boehringer Ingelheim GmbH, Corporate Board Divisions Human Resources, Research & Development and Medicine

    • Size: 3 kB
    • Last Update: 12.11.2012
  2. Prof Dr Dr Andreas Barner

    Prof. Dr Dr Andreas Barner,Boehringer Ingelheim GmbH, Corporate Board Divisions Human Resources, Research & Development and Medicine

    • Size: 6 kB
    • Last Update: 12.11.2012
  3. Prof Dr Dr Andreas Barner

    Prof. Dr Dr Andreas Barner,Boehringer Ingelheim GmbH, Corporate Board Divisions Human Resources, Research & Development and Medicine

    • Size: 2 MB
    • Last Update: 12.11.2012
  4. 06 September 2012 Cooperation ETH

    Boehringer Ingelheim und die ETH Zürich verkünden Forschungskooperation im Bereich Diabetes und Fettleibigkeit

    • Size: 9 kB
    • Last Update: 5.11.2012
  5. Prof. Dr Dr Andreas Barner

    Prof. Dr Dr Andreas Barner,Boehringer Ingelheim GmbH, Corporate Board Divisions Human Resources, Research & Development and Medicine

    • Size: 19 kB
    • Last Update: 12.11.2012
  6. Prof. Dr Wolfram Carius

    Dr Wolfram Carius, Boehringer Ingelheim GmbH, Corporate Board Divisions Biopharmaceuticals and Operations

    • Size: 21 kB
    • Last Update: 12.11.2012
  7. Engelbert Tjeenk Willink

    Engelbert Tjeenk Willink, Boehringer Ingelheim GmbH, Corporate Board Division Pharma Marketing and Sales

    • Size: 22 kB
    • Last Update: 12.11.2012
  8. World Diabetes Dax 2012

    • Size: 307 kB
    • Last Update: 14.11.2012
  9. Albert Boehringer

    • Size: 5 kB
    • Last Update: 14.11.2012
  10. Macha S, Rose P, Mattheus M, Cinca R, Pinnetti S, Broedl UC, Woerle HJ Phase I (1245.13; encore of ADA 2012)

    Macha S, Rose P, Mattheus M, Cinca R, Pinnetti S, Broedl UC, Woerle HJ Phase I (1245.13; encore of ADA 2012)

    • Size: 213 kB
    • Last Update: 6.11.2012